Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy DOI
Chunmei Yan, Yuxin Zhao, Xiaolian Liu

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(26), С. 33169 - 33181

Опубликована: Июнь 25, 2024

Inducing immunogenic cell death (ICD) is a promising strategy for cancer immunotherapy. Shikonin (SHK), naphthoquinone compound from Lithospermum erythrorhizon, can stimulate antitumor immunity by inducing ICD. Nevertheless, the immunogenicity of tumor cells killed SHK weak. Endoplasmic reticulum (ER) stress an important intracellular pathway ICD effect. Curcumin (CUR) directly induce ER disrupting Ca2+ homeostasis, which might enhance SHK-induced A self-delivery effect nanobooster (CS-PEG NPs) was developed self-assembly (ICD inducer) and CUR enhancer) with assistance DSPE-PEG2K chemoimmunotherapy. CS-PEG NPs possessed effective CT26 cellular uptake accumulation ability. Moreover, enhanced cytotoxicity against apoptosis promotion were achieved due to synergistic SHK. Notably, induced obvious homeostasis disruption, stress, Subsequently, neoantigens produced robust in vivo promoted dendritic maturation, further recruited activated cytotoxic T lymphocytes. Superior efficacy systemic observed CT26-bearing BALB/c mouse model without side effects major organs. This study offers strong

Язык: Английский

Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery DOI
Man Kyu Shim,

Suah Yang,

In‐Cheol Sun

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2022, Номер 183, С. 114177 - 114177

Опубликована: Март 1, 2022

Язык: Английский

Процитировано

119

Applications and challenges of ultra-small particle size nanoparticles in tumor therapy DOI
Jiaqi Xu,

Mengdi Song,

Zhou Fang

и другие.

Journal of Controlled Release, Год журнала: 2022, Номер 353, С. 699 - 712

Опубликована: Дек. 15, 2022

Язык: Английский

Процитировано

109

Recent advances and clinical translation of liposomal delivery systems in cancer therapy DOI Creative Commons
Jiayi Chen,

Siyuan Hu,

Man Sun

и другие.

European Journal of Pharmaceutical Sciences, Год журнала: 2024, Номер 193, С. 106688 - 106688

Опубликована: Янв. 1, 2024

The limitations of conventional cancer treatment are driving the emergence and development nanomedicines. Research in liposomal nanomedicine for therapy is rapidly increasing, opening up new horizons treatment. Liposomal nanomedicine, which focuses on targeted drug delivery to improve therapeutic effect while reducing damage normal tissues cells, has great potential field therapy. This review aims clarify advantages systems We describe recent understanding spatiotemporal fate liposomes organism after different routes administration. Meanwhile, various types liposome-based that exert their respective side effects were discussed. Moreover, combination agents with other therapies (such as photodynamic photothermal therapy) demonstrated enhanced tumor-targeting efficiency efficacy. Finally, opportunities challenges faced by liposome nanoformulations entering clinical highlighted.

Язык: Английский

Процитировано

54

Polydopamine-based nanostructures: A new generation of versatile, multi-tasking, and smart theranostic tools DOI Creative Commons
Matteo Battaglini, Melis Emanet, Alessio Carmignani

и другие.

Nano Today, Год журнала: 2024, Номер 55, С. 102151 - 102151

Опубликована: Янв. 9, 2024

Smart nanomaterials, thanks to their stimuli-responsive properties, represent a promising class of nanostructures for biomedical applications. Their ability undergo structural or functional changes in response specific external cues has been exploited the manipulation cellular activities as potential treatment various health disorders. Despite rather interesting properties and applications, most smart are composed inorganic materials, thus limiting translatability clinical applications due toxicity long-term accumulation concerns. Polydopamine can overcome limitations posed by nanomaterials high biocompatibility, biodegradability, antioxidant effects, pH-responsiveness, tunability, surface reactivity, photothermal conversion act photoacoustic contrast agents. In this review, we will present general analysis polydopamine Our aim is provide reader with state art concerning use organic nanoplatforms nanomedicine, also providing an current connected translation solutions these challenges.

Язык: Английский

Процитировано

37

Making the Complicated Simple: A Minimizing Carrier Strategy on Innovative Nanopesticides DOI Creative Commons
Wenjie Shangguan, Qiliang Huang, Huiping Chen

и другие.

Nano-Micro Letters, Год журнала: 2024, Номер 16(1)

Опубликована: Май 14, 2024

The flourishing progress in nanotechnology offers boundless opportunities for agriculture, particularly the realm of nanopesticides research and development. However, concerns have been raised regarding human environmental safety issues stemming from unrestrained use non-therapeutic nanomaterials nanopesticides. It is also important to consider whether current development strategy based on nanocarriers can strike a balance between investment return, if complex material composition genuinely improves efficiency, safety, circularity Herein, we introduced concept with minimizing carriers (NMC) prepared through prodrug design molecular self-assembly emerging as practical tools address limitations, compared it employing (NNC). We further summarized NMC examined potential challenges its preparation, performance, production. Overall, asserted that systems serve innovative driving force catalyzing green efficient revolution nanopesticides, offering way out predicament.

Язык: Английский

Процитировано

18

Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines DOI Creative Commons
Brankica Filipić, Ivana Pantelić, Ines Nikolić

и другие.

Vaccines, Год журнала: 2023, Номер 11(7), С. 1172 - 1172

Опубликована: Июнь 29, 2023

Ever since the development of first vaccine, vaccination has had great impact on global health, leading to decrease in burden numerous infectious diseases. However, there is a constant need improve existing vaccines and develop new strategies vaccine platforms that induce broader immune response compared traditional vaccines. Modern tend rely certain nanotechnology but are still expected be readily available easy for large-scale manufacturing durable response. In this review, we present an overview most promising nanoadjuvants nanoparticulate delivery systems discuss their benefits from tehchnological immunological standpoints as well objective drawbacks possible side effects. The presented nano alums, silica clay nanoparticles, nanoemulsions, adenoviral-vectored systems, adeno-associated viral vectors, vesicular stomatitis lentiviral virus-like particles (including bacteriophage-based ones) virosomes indicate developers can now choose different adjuvants and/or per requirement, specific combatting

Язык: Английский

Процитировано

34

Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies DOI Creative Commons
Pu-Sheng Wei,

Nagasri Thota,

Gresham John

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 375, С. 366 - 388

Опубликована: Сен. 18, 2024

Recent advancements in RNA therapeutics highlight the critical need for precision gene delivery systems that target specific organs and cells. Lipid nanoparticles (LNPs) have emerged as key vectors delivering mRNA siRNA, offering protection against enzymatic degradation, enabling targeted cellular uptake, facilitating cargo release into cytosol. This review discusses development optimization of organ- cell-specific LNPs, focusing on their design, mechanisms action, therapeutic applications. We explore innovations such DNA/RNA barcoding, which facilitates high-throughput screening precise adjustments formulations. address major challenges, including improving endosomal escape, minimizing off-target effects, enhancing efficiencies. Notable clinical trials recent FDA approvals illustrate practical applications future potential LNP-based therapies. Our findings suggest while considerable progress has been made, continued research is essential to resolve existing limitations bridge gap between pre-clinical evaluation safety efficacy therapeutics. highlights dynamic LNP research. It outlines a roadmap RNA-based medicine.

Язык: Английский

Процитировано

18

Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy DOI Creative Commons
Zhonglei Wang, Liyan Yang

Pharmacological Research, Год журнала: 2024, Номер 203, С. 107150 - 107150

Опубликована: Март 21, 2024

Cancer, with its diversity, heterogeneity, and complexity, is a significant contributor to global morbidity, disability, mortality, highlighting the necessity for transformative treatment approaches. Photodynamic therapy (PDT) has aroused continuous interest as viable alternative conventional cancer treatments that encounter drug resistance. Nanotechnology brought new advances in medicine shown great potential delivery treatment. For precise efficient therapeutic utilization of such tumor approach high spatiotemporal selectivity minimal invasiveness, carrier-free noncovalent nanoparticles (NPs) based on chemo-photodynamic combination essential. Utilizing natural products foundation nanodrug development offers unparalleled advantages, including exceptional pharmacological activity, easy functionalization/modification, well biocompatibility. The natural-product-based, carrier-free, NPs revealed excellent synergistic anticancer activity comparison free photosensitizers bioactive products, representing an favorable avenue improve efficacy. Herein, comprehensive summary current strategies representative application examples past decade (such paclitaxel, 10-hydroxycamptothecin, doxorubicin, etoposide, combretastatin A4, epigallocatechin gallate, curcumin) therapy. We highlight insightful design synthesis smart aim enhance PDT Meanwhile, we discuss future challenges opportunities associated these provide enlightenment, spur innovative ideas, facilitate PDT-mediated clinical transformation.

Язык: Английский

Процитировано

17

Persistent luminescence-activated Janus nanomotors with integration of photodynamic and photothermal cancer therapies DOI

Zhanlin Zhang,

Tian Xia, Pan Ran

и другие.

Chemical Engineering Journal, Год журнала: 2022, Номер 457, С. 141226 - 141226

Опубликована: Дек. 29, 2022

Язык: Английский

Процитировано

31

Hyaluronic acid-functionalized graphene-based nanohybrids for targeted breast cancer chemo-photothermal therapy DOI Creative Commons
Rita Lima‐Sousa, Bruna L. Melo, António Mendonça

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер 651, С. 123763 - 123763

Опубликована: Янв. 2, 2024

Nanomaterials' application in cancer therapy has been driven by their ability to encapsulate chemotherapeutic drugs as well reach the tumor site. Nevertheless, nanomedicines' translation limited due lack of specificity towards cells. Although nanomaterials' surface can be coated with targeting ligands, such mostly achieved through non-covalent functionalization strategies that are prone premature detachment. Notwithstanding, cells often establish resistance mechanisms impair effect loaded drugs. This bottleneck may addressed using near-infrared (NIR)-light responsive nanomaterials. The NIR-light triggered hyperthermic generated these nanomaterials cause irreversible damage or sensitize them chemotherapeutics' action. Herein, a novel covalently functionalized targeted NIR-absorbing nanomaterial for chemo-photothermal was developed. For such, dopamine-reduced graphene oxide were bonded hyaluronic acid, and then doxorubicin (DOX/HA-DOPA-rGO). produced showed suitable physicochemical properties, high encapsulation efficiency, photothermal capacity. vitro studies revealed cytocompatible display an improved uptake CD44-overexpressing breast Importantly, combination DOX/HA-DOPA-rGO NIR light reduced cells' viability just 23 %, showcasing potential therapy.

Язык: Английский

Процитировано

9